Prick-Test Lycopersicum
Prick-Test Lycopersicum is a medicine authorised by Swissmedic under authorisation number 61728. The authorisation holder is Dermapharm AG. The medicinal product code is Allergen: diagnostic and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 October 2010 and the authorisation is valid without a time limit. ATC code V04CL places the medicine in the group Diagnostic agents.
| Authorisation number | 61728 |
|---|---|
| Name | Prick-Test Lycopersicum |
| Full name | Prick-Test Lycopersicum, Pricktestlösung |
| Authorisation holder | Dermapharm AG |
| Medicinal product code | Allergen: diagnostic |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | V04CL |
| First authorisation | 18 October 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Prick-Test Lycopersicum, Pricktestlösung | A | 18 October 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 3 ml | Flasche(n) | V04CL | 14.03.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Prick-Test Lycopersicum authorised in Switzerland?
Yes. Prick-Test Lycopersicum is authorised by Swissmedic under authorisation number 61728, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Prick-Test Lycopersicum have?
Prick-Test Lycopersicum is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Prick-Test Lycopersicum?
The authorisation holder is Dermapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.